Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

56
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
56
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130
Regression Toward the Mean01:52

Regression Toward the Mean

6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

149
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
149
Actuarial Approach01:20

Actuarial Approach

79
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
79
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOS.

International journal of chronic obstructive pulmonary disease·2024
Same author

Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.

International journal of chronic obstructive pulmonary disease·2022
Same author

Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Exacerbation Outcomes in Patients with COPD without a Recent Exacerbation History: A Subgroup Analysis of KRONOS.

International journal of chronic obstructive pulmonary disease·2021
Same author

The attributable estimand: A new approach to account for intercurrent events.

Pharmaceutical statistics·2020
Same author

Fibrinogen does not relate to cardiovascular or muscle manifestations in COPD: cross-sectional data from the ERICA study.

Thorax·2018
Same author

Impact of a five-dimensional framework on R&D productivity at AstraZeneca.

Nature reviews. Drug discovery·2018

相关实验视频

Updated: Jul 7, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K

算法基准调制:一种新的方法来开发临床研究的成功率.

Bart Ja Willigers1, Sridevi Nagarajan1,2, Serban Ghiorghui1

  • 1AstraZeneca, Cambridge, UK.

Clinical trials (London, England)
|December 21, 2023
PubMed
概括

阿斯特拉泽内卡开发了一个结构化的算法,以改善临床试验的技术成功概率 (PTS) 评估. 这种新的方法,根据历史数据进行验证,旨在在制药决策中实现更一致和更有效的PTS评估.

关键词:
临床试验 临床试验是指临床试验.保证计算的保证计算.基准测试 (benchmarking) 是一种比较的方法.成功的概率成功的概率.定量决策 定量决策的使用

更多相关视频

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.6K

相关实验视频

Last Updated: Jul 7, 2025

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

4.6K

科学领域:

  • 制药行业 制药行业 制药行业
  • 临床试验的管理管理.
  • 决策分析 决策分析

背景情况:

  • 准确的技术成功概率 (PTS) 对于制药决策至关重要.
  • 目前用于估计PTS的方法包括功率计算,保证计算和行业基准,通常具有主观调整.
  • 阿斯特拉泽内卡使用了保证计算和行业基准,并结合了主观调制.

研究的目的:

  • 引入和验证一种新的,结构化的算法,用于调节技术成功概率 (PTS) 值.
  • 提高关键药物研究中PTS评估的一致性和效率.
  • 提供一个工具,帮助制药行业应对PTS估计方面的挑战.

主要方法:

  • 开发一个简单的算法,基于一套全面的多选择题,用于PTS调制.
  • 算法结构在主观调制过程中历史上考虑过的问题.
  • 验证涉及一组57个第三阶段PTS评估.

主要成果:

  • 根据57次第三阶段评估,AstraZeneca的历史PTS估计被发现是相当准确的.
  • 在主观调制和新型调制算法之间观察到强烈的相关性.
  • 这些发现为新的PTS调制方法的有效性提供了信心.

结论:

  • PTS调制算法解决了传统保证计算和非调制基准的局限性,例如选择偏差和模拟各种因素的困难.
  • 它允许考虑到项目特定的考虑因素,与通用行业基准不同.
  • 这种方法允许更一致的PTS评估,减少关键研究的努力.